ATLASCorcept Therapeutics (CORT) earnings date: Nov 3, 2026
Corcept Therapeutics (CORT) reports earnings for the quarter ended Sep 30, 2026 on Tue, Nov 3, 2026, after the close. Analysts expect EPS of $0.68.
Source: company filings and exchange data · Updated Nov 2, 2026
Corcept Therapeutics reports on Nov 3, 2026. One email the day before, with ATLAS’s read on Corcept Therapeutics. You can switch it off at any time.
Alert me before CORT reportsFree to start. Creating an account takes under a minute.
CORT earnings at a glance
| Next report (confirmed) | Tue, Nov 3, 2026 |
|---|---|
| Time | After the close |
| Period | Quarter ended Sep 30, 2026 |
| EPS estimate | $0.68 |
| Last report | Jul 29, 2026 · Beat |
| Beat rate (last 5 reports) | 2 of 5 (40%) |
| Average EPS surprise | +70.0% |
| Average move around a report | ±9.6% (last 5) |
| Sector | Healthcare · Biotechnology |
Corcept Therapeutics earnings history: last 5 reports
Corcept Therapeutics last reported on Jul 29, 2026: EPS of $0.36 against an estimate of $0.06 (+500.0% surprise), a beat.
| Report date | EPS est. | EPS actual | Surprise | Result | Move* |
|---|---|---|---|---|---|
| Jul 29, 2026 | $0.06 | $0.36 | +500.0% | Beat | +25.6% |
| Jul 18, 2026 | $0.39 | $0.38 | -2.6% | Miss | +5.7% |
| Apr 30, 2026 | -$0.14 | -$0.30 | -114.3% | Miss | +10.4% |
| Mar 19, 2026 | $0.16 | $0.17 | +6.3% | Beat | +4.0% |
| Feb 24, 2026 | $0.33 | $0.20 | -39.4% | Miss | +2.5% |
*Move: change in the closing price from the last close before the report day to the close the day after it, so it captures the reaction whether the company reported before the open or after the close.
ATLAS view on CORT before the report
| Last price | $81.12 (-5.6%) |
|---|---|
| ATLAS chance of a higher price in 1 month | 46% |
| Likely 1-month range (50%) | $69.02 – $91.30 |
| Normal 1-day range (±1σ) | ±4.8% |
| ATLAS fair value | $42.79 ($32.86 – $57.60) · price is 90% above |
These figures come from the same calibrated model and valuation as the Corcept Therapeutics stock page. They describe an ordinary period, not the earnings reaction itself, which is usually wider and can go either way.
Get the full ATLAS analysis for CORT
See the fair value, the probability range and the earnings history of Corcept Therapeutics on its ATLAS page.
Corcept Therapeutics (CORT) stock analysisPlans from €3.99 a month.
Corcept Therapeutics earnings: frequently asked questions
When does Corcept Therapeutics (CORT) report earnings?
Corcept Therapeutics is scheduled to report on Tuesday, November 3, 2026, after the close. ATLAS only shows a confirmed date when the company or the exchange data provides one; check the investor relations page for the call details.
What is the EPS estimate for CORT?
The consensus EPS estimate for the quarter ended Sep 30, 2026 is $0.68 per share (USD). Estimates can change before the report.
How often does CORT beat earnings estimates?
Of its last 5 reports with a recorded result, Corcept Therapeutics beat the EPS estimate 2 times; the average surprise was +70.0%. Past results do not predict the next one.
How much does CORT move around earnings?
Over its last 5 reports the stock moved an average of 9.6% (absolute, from the close before the report day to the close after it), and finished higher 5 of 5 times.
Did Corcept Therapeutics beat earnings estimates last quarter?
Corcept Therapeutics last reported on Jul 29, 2026: EPS of $0.36 against an estimate of $0.06 (+500.0% surprise), a beat.
How much does CORT usually move in a day?
On a normal trading day the ATLAS model puts CORT’s one-day range at about ±4.8%, with a 49% chance of closing higher. This is not an options-implied earnings move; earnings days are usually wider.
Also reporting on Tue, Nov 3, 2026
Educational information, not investment advice. Disclaimer